Mesa Laboratories (MLAB) Stock Analysis & Winston Score
Mesa Laboratories makes specialized testing and measurement tools used in healthcare, pharmaceuticals, and food safety. Its core products include biological indicators (used to verify that sterilization equipment is working properly), continuous monitoring systems, and calibration instruments. The company sells mainly to hospitals, drug manufacturers, and food processing companies that need to prove their equipment meets strict safety standards. Mesa Labs earns revenue by selling both physical instruments and consumable products — like the biological indicators that get used up and must be reordered regularly. It operates primarily in North America and Europe, with annual revenues around $200 million. The recurring consumables business gives it some pricing stability, but the company has grown partly through acquisitions, which has left it carrying meaningful debt and a low return on invested capital. The key challenge going forward is improving profitability and integrating past acquisitions efficiently, rather than relying on further deal-making to drive growth.
Winston Score: 53/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (14/30)
- Growth: Mixed (7/20)
- Cash Flow: Exceptional (10/10)
- Stability: Good (6/10)
- Valuation: Good (5/10)
- Ownership: Good (10/15)
Key Facts
Price: $124.76
Market Cap: $698M
Sector: Healthcare
Industry: Medical - Equipment & Services
Exchange: NASDAQ


